Literature DB >> 17064946

Imaging study scores for ankylosing spondylitis.

Daniel Wendling1, Eric Toussirot, Gérald Streit, Clément Prati.   

Abstract

Scoring systems have been developed for radiographs and magnetic resonance imaging (MRI) in patients with ankylosing spondylitis (AS). Radiographic scores focus on chronic structural alterations, which occur slowly and show little sensitivity to change in the short-term. Recent clinical studies used the modified Stoke ankylosing spondylitis spine score (mSASSS), which evaluates the cervical and lumbar spine. TNF antagonists were found to modify the mSASSS, indirectly supporting a structural effect of these agents. MRI using specific sequences is a potent tool for evaluating inflammation, most notably at the spine. MRI has proved sensitive to change in patients taking TNF antagonists. An outcome measures in rheumatology clinical trials (OMERACT) task force is working on standardizing MRI scores for the spine and sacroiliac joints.

Entities:  

Mesh:

Year:  2006        PMID: 17064946     DOI: 10.1016/j.jbspin.2006.03.007

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  4 in total

1.  Evaluation of complex appearance in vascularity of sacroiliac joint in ankylosing spondylitis by color Doppler ultrasonography.

Authors:  Jiaan Zhu; Chunyan Xing; Yeqing Jiang; Yizhou Hu; Bing Hu; Niansong Wang
Journal:  Rheumatol Int       Date:  2010-07-25       Impact factor: 2.631

2.  Spinal inflammation by magnetic resonance imaging in patients with ankylosing spondylitis: association with disease activity and outcome parameters.

Authors:  Sefika Konca; Dilek Keskin; Deniz Cılız; Hatice Bodur; Bülent Sakman
Journal:  Rheumatol Int       Date:  2011-12-11       Impact factor: 2.631

3.  Characterization of new bone formation in gout: a quantitative site-by-site analysis using plain radiography and computed tomography.

Authors:  Nicola Dalbeth; Aaron Milligan; Anthony J Doyle; Barnaby Clark; Fiona M McQueen
Journal:  Arthritis Res Ther       Date:  2012-07-13       Impact factor: 5.156

4.  Celastrol inhibits prostaglandin E2-induced proliferation and osteogenic differentiation of fibroblasts isolated from ankylosing spondylitis hip tissues in vitro.

Authors:  Yu-Cong Zou; Xian-Wen Yang; Shi-Guo Yuan; Pei Zhang; Yi-Kai Li
Journal:  Drug Des Devel Ther       Date:  2016-03-07       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.